
AbCellera Biologics ABCL
$ 3.74
3.6%
Annual report 2025
added 02-24-2026
AbCellera Biologics Total Inventories 2011-2026 | ABCL
Annual Total Inventories AbCellera Biologics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.34 M | 6.34 M | 6.34 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Codexis
CDXS
|
1.8 M | $ 1.02 | 1.49 % | $ 74.9 M | ||
|
Cerus Corporation
CERS
|
38.2 M | $ 2.6 | 1.37 % | $ 480 M | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Collegium Pharmaceutical
COLL
|
40.9 M | $ 41.75 | 0.19 % | $ 1.32 B | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
12.9 M | $ 36.14 | 1.23 % | $ 3.75 B | ||
|
Amarin Corporation plc
AMRN
|
259 M | $ 13.98 | 1.27 % | $ 5.7 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
37.2 M | $ 23.77 | 2.99 % | $ 2.91 B | ||
|
CorMedix
CRMD
|
2.11 M | $ 7.16 | 0.42 % | $ 364 M | ||
|
CEL-SCI Corporation
CVM
|
1.02 M | $ 3.88 | -8.92 % | $ 247 M |